Biotechnology - Politics, North America

Filter

Current filters:

PoliticsNorth America

Popular Filters

US lawmakers question price of Gilead’s Sovaldi

US lawmakers question price of Gilead’s Sovaldi

24-03-2014

Three leading US Congressmen have written to John Martin, chief executive of US biotech firm Gilead Sciences,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPoliticsPricingRegulationSovaldiUSA

OncoMed CEO presses for better environment for biopharma innovation, at House hearings

13-12-2013

The case for encouraging biopharma innovation was presented yesterday at the US House Committee on Oversight…

BiotechnologyNorth AmericaOncoMed PharmaceuticalsPoliticsRegulationResearch

USA’s BIO expresses serious concerns on Innovation Act, HR 3309

04-12-2013

The US trade group Biotechnology Industry Organization (BIO) has expressed grave concerns relating to…

BiotechnologyLegalNorth AmericaPatentsPolitics

California Assembly passes controversial biosimilars bill

29-08-2013

In the USA this week, the California Assembly has passes legislation that would allow pharmacists to…

BiotechnologyGenericsLegalNorth AmericaPoliticsRegulation

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions

05-08-2013

In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

HAI Europe questions pharma commitment to clinical trial data transparency, claiming leaked documents suggest otherwise

29-07-2013

Consumer advocacy Health Action International (HAI) Europe says it welcomes any initiative that grants…

BiotechnologyEuropeNorth AmericaPharmaceuticalPoliticsRegulationResearch

Bipartisan Bill exempting FDA user fees from sequestration introduced in USA

22-07-2013

A bipartisan group of US House of Representatives Members last week introduced the FDA Safety Over Sequestration…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalPolitics

US FY 2014 budget continues push to curb patent settlements, shorten biologics exclusivity; a lawyer's view

12-04-2013

At first look, the US Food and Drug Administration appears to have fared rather well under President…

BiotechnologyGenericsNorth AmericaPatentsPoliticsRegulationResearch

President Obama's 2014 budget proposal a mixed bag for pharma

11-04-2013

US President Barack Obama $3.77 trillion budget proposal for fiscal 2014 delivers mixed news for the…

BiotechnologyFinancialHealthcareNorth AmericaPharmaceuticalPolitics

Mixed industry views on Virginia's law on biosimilar substitutions

25-03-2013

A new law in the US state of Virginia signed into law last week by Governor Bob McDonnell - designed…

BiotechnologyGenericsLegalNorth AmericaPoliticsRegulation

US biotech giants lobbying to block biosimilars, NTY claims

31-01-2013

Some of the USA's biggest biotechnology companies are lobbying intensively to limit generic competition…

AmgenBiotechnologyGenentechGenericsNorth AmericaPoliticsRegulation

Canadian Senate committee finds faults in current clinical trials system

05-11-2012

The absence of a standardized approach to research ethics review significantly impacts the time required…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulationResearch

US House and Senate reconcile PDUFA reauthorization legislation

20-06-2012

The US Congress has released a reconciled Prescription Drug User Fee Act (PDUFA) reauthorization bill…

BiotechnologyLegalNorth AmericaPharmaceuticalPoliticsRegulation

US legislation could block public access to drug safety information, claim consumer groups

30-05-2012

A provision in the Food and Drug Administration Reform Act that would block public access to potentially…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

US Senate passing of FDA Safety and Innovation Act lauded by biotech and pharma industry

28-05-2012

The US Senate approved the Food and Drug Administration Safety and Innovation Act (FDASIA), which includes…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalPoliticsRegulation

Pharma companies "must be held fully accountable for defrauding US government," says Public Citizen

23-05-2012

Public Citizen strongly supports a measure proposed by US Senator Bernie Sanders (Independent, Vermont)…

BiotechnologyLegalMarkets & MarketingNorth AmericaPharmaceuticalPolitics

Foreign efforts to lure US biopharmaceutical companies

20-05-2012

Despite increasing budget pressures, countries around the world are making substantial investments in…

BiotechnologyFinancialGlobalNorth AmericaPharmaceuticalPoliticsResearch

Sunshine Act data collection delayed to January 2013, says USA's CMS

08-05-2012

In a web site posting last week, The US Center for Medicare and Medicaid Services (CSM) announced that…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

BIO asks US House Committee on Ways and Means to extend critical tax provisions; backs Obama Bioeconomy Blueprint

29-04-2012

US trade group the Biotechnology Industry Organization (BIO) has submitted a statement for the record…

BiotechnologyFinancialNorth AmericaPolitics

US Senators Burr and Coburn introduce legislation to reform FDA

19-04-2012

US Senators Richard Burr (Republican, North Carolina) and Tom Coburn (Republican, Oklahoma) this week…

BiotechnologyLegalNorth AmericaPharmaceuticalPoliticsRegulation

COMPANY SPOTLIGHT

Menarini

Back to top